 The investigators will conduct a randomized, double-blind study including 460 patients 2x230, who will be randomized to receive 100mg acetylsalicylic aciddaily, intravenous or a placebo 0,9 sodium-choride solution to assess whether acetylsalicylic acid reduces the mortality of medical intensive care unit patients. 